Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

NCT00201279 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Oral Cavity
Squamous Cell Carcinoma

Interventions

DRUG: 13-cis Retino Acid

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]